ES493092A0 - Procedimiento de preparacion de amino-eteres oxidos - Google Patents

Procedimiento de preparacion de amino-eteres oxidos

Info

Publication number
ES493092A0
ES493092A0 ES493092A ES493092A ES493092A0 ES 493092 A0 ES493092 A0 ES 493092A0 ES 493092 A ES493092 A ES 493092A ES 493092 A ES493092 A ES 493092A ES 493092 A0 ES493092 A0 ES 493092A0
Authority
ES
Spain
Prior art keywords
amino
procedure
preparation
ethers
oxides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES493092A
Other languages
English (en)
Other versions
ES8103020A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SYNTHESE SOC IND PROD
Industrielle de Produits de Synthese Ste
Original Assignee
SYNTHESE SOC IND PROD
Industrielle de Produits de Synthese Ste
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SYNTHESE SOC IND PROD, Industrielle de Produits de Synthese Ste filed Critical SYNTHESE SOC IND PROD
Publication of ES493092A0 publication Critical patent/ES493092A0/es
Publication of ES8103020A1 publication Critical patent/ES8103020A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/64—One oxygen atom attached in position 2 or 6
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/65—One oxygen atom attached in position 3 or 5

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
ES493092A 1979-07-11 1980-07-04 Procedimiento de preparacion de amino-eteres oxidos Expired ES8103020A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7917986A FR2460919A1 (fr) 1979-07-11 1979-07-11 Amino-ethers oxydes, leur procede de preparation et leur application en therapeutique

Publications (2)

Publication Number Publication Date
ES493092A0 true ES493092A0 (es) 1981-02-16
ES8103020A1 ES8103020A1 (es) 1981-02-16

Family

ID=9227765

Family Applications (1)

Application Number Title Priority Date Filing Date
ES493092A Expired ES8103020A1 (es) 1979-07-11 1980-07-04 Procedimiento de preparacion de amino-eteres oxidos

Country Status (11)

Country Link
US (1) US4301163A (es)
JP (1) JPS5615250A (es)
BE (1) BE884212A (es)
CA (1) CA1148547A (es)
CH (1) CH644348A5 (es)
DE (1) DE3026201A1 (es)
ES (1) ES8103020A1 (es)
FR (1) FR2460919A1 (es)
GB (1) GB2054588B (es)
IT (1) IT1136190B (es)
NL (1) NL190237C (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4824868A (en) * 1982-09-07 1989-04-25 Ciba-Geigy Corporation Propylamine derivatives useful for the treatment of dementia
US4692469A (en) * 1982-09-07 1987-09-08 Ciba-Geigy Corporation Propylamine derivatives
DE3372283D1 (en) * 1982-09-07 1987-08-06 Ciba Geigy Ag Propylamine derivatives, process for their preparation, pharmaceutical compositions containing these compounds, and their therapeutical use
ZW6584A1 (en) * 1983-04-18 1985-04-17 Glaxo Group Ltd Phenethanolamine derivatives
US5245080A (en) * 1989-02-20 1993-09-14 Jouveinal Sa (+)-1-[(3,4,5-trimethoxy)-benzyloxymethyl]-1-phenyl-N,N-dimethyl-N-propylamine, process for preparing it and its therapeutical use
FR2643369B1 (fr) * 1989-02-20 1991-07-05 Jouveinal Sa La (+) 1-((3,4,5-trimethoxy) benzyloxymethyl)-1-phenyl-n,n-dimethyl-n-propylamine, son procede de preparation et son application en therapeutique
US5266599A (en) * 1989-02-20 1993-11-30 Jouveinal S.A. Use of (+)-1-[(3,4,5-trimethoxy)-benzyloxymethyl]-1-phenyl-N,N-dimethyl-n-propylamine to increase gastric discharge in a subject
US5472978A (en) * 1991-07-05 1995-12-05 Merck Sharp & Dohme Ltd. Aromatic compounds, pharmaceutical compositions containing them and their use in therapy
EP0593557B1 (en) * 1991-07-05 1996-01-31 MERCK SHARP & DOHME LTD. Aromatic compounds, pharmaceutical compositions containing them and their use in therapy
US5495047A (en) * 1991-07-10 1996-02-27 Merck, Sharp & Dohme (Ltd.) Fused tricyclic compounds, pharmaceutical compositions containing them and their use in therapy
DE69208089T2 (de) * 1991-07-10 1996-08-22 Merck Sharp & Dohme Aromatische verbindungen diese enthaltende pharmazeutische zusammensetzungen und ihre therapeutische verwendung
US5328927A (en) * 1992-03-03 1994-07-12 Merck Sharpe & Dohme, Ltd. Hetercyclic compounds, processes for their preparation and pharmaceutical compositions containing them
GB9211193D0 (en) * 1992-05-27 1992-07-08 Merck Sharp & Dohme Therapeutic agents
AU4718093A (en) * 1992-07-31 1994-03-03 Merck Sharp & Dohme Limited Substituted amines as tachykinin receptor antagonists
WO1996006068A1 (fr) * 1994-08-22 1996-02-29 Yoshitomi Pharmaceutical Industries, Ltd. Compose benzenique et son utilisation medicale
US5948820A (en) 1994-08-22 1999-09-07 Yoshitomi Pharmaceutical Industries, Ltd. Benzene compound and pharmaceutical use thereof
CN100406437C (zh) 2002-01-11 2008-07-30 三共株式会社 氨基醇衍生物或膦酸衍生物以及含有它们的药物组合物
US6986901B2 (en) * 2002-07-15 2006-01-17 Warner-Lambert Company Llc Gastrointestinal compositions
CA2491797A1 (en) * 2002-07-10 2004-01-22 Warner-Lambert Company Llc Gastrointestinal compositions
EP1549302A1 (en) * 2002-07-10 2005-07-06 Warner-Lambert Company LLC Gastrointestinal compositions comprising gaba derivatives
US20040010035A1 (en) * 2002-07-15 2004-01-15 Ciociola Arthur A. Gastrointestinal compositions
BRPI0507944A (pt) 2004-02-24 2007-07-24 Sankyo Co composição farmacêutica
SE0400968D0 (sv) * 2004-04-14 2004-04-14 Astrazeneca Ab Aryl glycine ether derivatives and their use
US7879913B2 (en) * 2005-06-28 2011-02-01 Catholic Healthcare West Iptakalim hydrochloride for decreasing nicotine use
KR20090021346A (ko) * 2006-06-06 2009-03-03 안티브 테라퓨틱스 인크. 트리메부틴 및 ｎ-데스메틸 트리메부틴 염

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2649445A (en) * 1948-02-28 1953-08-18 Bristol Lab Chloracetic acid ester of diphenyl ethanols
ES251290A1 (es) * 1958-08-21 1960-04-01 Parke Davis & Co Un procedimiento para la producciën de alcohilaminas arilsustituidas
GB1119835A (en) * 1964-07-20 1968-07-17 Analyses Et De Rech S Biolog M Process for the preparation of basic ethers
US4194009A (en) * 1974-01-10 1980-03-18 Eli Lilly And Company Aryloxyphenylpropylamines for obtaining a psychotropic effect
US4207343A (en) * 1978-06-22 1980-06-10 Eli Lilly And Company 1-Phenyl-3-(substituted phenoxy)propylamines

Also Published As

Publication number Publication date
GB2054588A (en) 1981-02-18
US4301163A (en) 1981-11-17
JPS6253504B2 (es) 1987-11-10
JPS5615250A (en) 1981-02-14
US4301163B1 (es) 1990-01-23
IT8012595A0 (it) 1980-07-11
NL190237B (nl) 1993-07-16
FR2460919A1 (fr) 1981-01-30
DE3026201C2 (es) 1990-11-08
NL8003601A (nl) 1981-01-13
CH644348A5 (fr) 1984-07-31
FR2460919B1 (es) 1983-11-10
ES8103020A1 (es) 1981-02-16
IT1136190B (it) 1986-08-27
DE3026201A1 (de) 1981-02-26
BE884212A (fr) 1981-01-08
NL190237C (nl) 1993-12-16
GB2054588B (en) 1983-06-29
CA1148547A (en) 1983-06-21

Similar Documents

Publication Publication Date Title
ES493092A0 (es) Procedimiento de preparacion de amino-eteres oxidos
ES491913A0 (es) Procedimiento para la preparacion de betainas
AR227645A1 (es) Procedimiento para la preparacion de oxoalcohilxantinas
ES495179A0 (es) Procedimiento para la preparacion de polieterpoliaminas
ES493774A0 (es) Procedimiento para la preparacion de 3-amino-sidnoniminas
ES497100A0 (es) Procedimiento para la preparacion de sulfonilureas
AR222691A1 (es) Procedimiento de preparacion de derivados hidroxi-de 2-isopropilamino-pirimidina
ES491618A0 (es) Procedimiento de preparacion de un cloro-2-propionato de al-cohilo
TR20597A (tr) Etilen oksidin hazirlanisi icin usul
ES493300A0 (es) Procedimiento para la preparacion de acilureas
ES487746A0 (es) Procedimiento para la preparacion de bis-estiril-benceno
ES491527A0 (es) Procedimiento para la preparacion de tiazoliliden-oxo-pro- pionitrilos
ES494856A0 (es) Procedimiento para la preparacion de n-aril-n-acil-3-amino- oxazolidin-2-onas
ES490421A0 (es) Procedimiento para la preparacion de diestirilbencenos
ES490420A0 (es) Procedimiento para la preparacion de diestirilbifenilos
ES489880A0 (es) Un procedimiento de preparacion de un trihalometilcarbonato
AR225159A1 (es) Procedimiento para la preparacion de l-alpha-gliceril-fosforilcolina
IT1133021B (it) Procedimento per la preparazione di trialcossisilanoli
ES490620A0 (es) Procedimiento para la preparacion de 3-alcoxi-6-alquiliden- hidracionopiridacina
ES489115A0 (es) Procedimiento de preparacion de polieteres glicidicos de po-lifenoles
ES497659A0 (es) Procedimiento para la preparacion de sulfonilureas
ES493001A0 (es) Procedimiento para la preparacion de metilglioxal
ES491738A0 (es) Procedimiento de preparacion de trihalogenuros organoestan- nicos
AR223383A1 (es) Procedimiento para la preparacion de 2-isopropilamino-pirimidina
ES497099A0 (es) Procedimiento para la preparacion de sulfonilureas

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20010217